Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
Public ClinicalTrials.gov record NCT05199818. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Palonosetron HCl Buccal Film Versus IV Palonosetron for Prevention of Chemotherapy-induced Nausea and Vomiting in Cancer Patients Receiving Moderately Emetogenic Chemotherapy
Study identification
- NCT ID
- NCT05199818
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Xiamen LP Pharmaceutical Co., Ltd
- Industry
- Enrollment
- 328 participants
Conditions and interventions
Conditions
Interventions
- Palonosetron HCl Buccal Film 0.5 mg Drug
- IV Palonosetron 0.25 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2022
- Primary completion
- Aug 31, 2023
- Completion
- Oct 31, 2023
- Last update posted
- Jan 19, 2023
2022 – 2023
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer & Research Centers | Chandler | Arizona | 85224 | Recruiting |
| Pacific Cancer Medical Center | Anaheim | California | 92801 | Recruiting |
| Watson Clinic | Lakeland | Florida | 33805 | Recruiting |
| Lakes Research | Miami Lakes | Florida | 33014 | Recruiting |
| Florida Cancer Affiliates | Ocala | Florida | 34474 | Recruiting |
| Summit Cancer Care | Savannah | Georgia | 31405 | Recruiting |
| Edward H. Kaplan MD & Associates | Skokie | Illinois | 60076 | Recruiting |
| Orchard Healthcare research, Inc. | Skokie | Illinois | 60077 | Recruiting |
| American Oncology Partners of Maryland, PA | Bethesda | Maryland | 20817 | Recruiting |
| Hattiesburg Clinic Hematology/Oncology | Hattiesburg | Mississippi | 39401 | Recruiting |
| St. Vincent Frontier Cancer Center | Billings | Montana | 59102 | Recruiting |
| Tri-County Hematology & Oncology Associates | Massillon | Ohio | 44646 | Recruiting |
| Gettysburg Cancer Center | Gettysburg | Pennsylvania | 17325 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05199818, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 19, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05199818 live on ClinicalTrials.gov.